Parkinson’s Disease: Vercise Deep Brain Stimulation Demonstrates Efficacy for Over a Year
source: pixabay.com

Parkinson’s Disease: Vercise Deep Brain Stimulation Demonstrates Efficacy for Over a Year

According to a story from Parkinson's News Today, the Vercise system, developed by Boston Scientific as a method of deep brain stimulation, was able to provide benefit to Parkinson's disease…

Continue Reading Parkinson’s Disease: Vercise Deep Brain Stimulation Demonstrates Efficacy for Over a Year

Sixty Year Old Multiple Myeloma Patient in Wuhan, China Treated Successfully with Tocilizumab for COVID-19

  Dr. Changcheng Zheng of the University of Science, China, recently spoke to Cancer Network about a case study indicating that tocilizumab (Actemra) could effectively treat people with multiple myeloma…

Continue Reading Sixty Year Old Multiple Myeloma Patient in Wuhan, China Treated Successfully with Tocilizumab for COVID-19

ICYMI: Una Nueva Encuesta Busca Respuestas Sobre Cómo COVID-19 Está Afectando a Pacientes con Enfermedades Raras en los Estados Unidos

Por Natalie Homan de In The Cloud Copy En los Estados Unidos, una enfermedad se considera "rara" si afecta a menos de 200,000 Estadounidenses en un momento dado. Las enfermedades…

Continue Reading ICYMI: Una Nueva Encuesta Busca Respuestas Sobre Cómo COVID-19 Está Afectando a Pacientes con Enfermedades Raras en los Estados Unidos
Arimoclomol Receives the Fast Track Designation for the Treatment of ALS
source: pixabay.com

Arimoclomol Receives the Fast Track Designation for the Treatment of ALS

CytRx Corporation has recently received the Fast Track designation for their ALS treatment, arimoclomol. This status was also given for the treatment of Niemann-Pick disease and sporadic Inclusion Body Myositis…

Continue Reading Arimoclomol Receives the Fast Track Designation for the Treatment of ALS
This Skin Patch was Able to Improve Motor Function in Advanced Parkinson’s Disease
source: pixabay.com

This Skin Patch was Able to Improve Motor Function in Advanced Parkinson’s Disease

According to a story from Parkinson's News Today, ropinirole (marketed as Requip) skin patches proved capable of improving motor function in patients with advanced Parkinson's disease when compared to placebo.…

Continue Reading This Skin Patch was Able to Improve Motor Function in Advanced Parkinson’s Disease
TNF Inhibitors Increase Risk of Central Nervous System Inflammation for Patients with Autoimmune Disorders
mohamed_hassan / Pixabay

TNF Inhibitors Increase Risk of Central Nervous System Inflammation for Patients with Autoimmune Disorders

According to MedScape, tumor necrosis factor (TNF) inhibitors present severe issues for patients with autoimmune disorders. In particular, patients exposed to TNF inhibitors may experience inflammation throughout their central nervous…

Continue Reading TNF Inhibitors Increase Risk of Central Nervous System Inflammation for Patients with Autoimmune Disorders
Study: ANAVEX 3-71 as a Treatment for Neurodegenerative Diseases
source: pixabay.com

Study: ANAVEX 3-71 as a Treatment for Neurodegenerative Diseases

Anavex Life Sciences Corporation has recently announced that they will conduct a clinical trial for their small molecule, ANAVEX®3-71. This therapy is intended to treat neurodegenerative and neurodevelopmental conditions, such…

Continue Reading Study: ANAVEX 3-71 as a Treatment for Neurodegenerative Diseases
Is There Too Much Variability in Hyperkalemia Management?
Photo by Robina Weermeijer on Unsplash

Is There Too Much Variability in Hyperkalemia Management?

  The virtually-held National Kidney Foundation 2020 Spring Clinical Meetings explored various topics relating to nephrological conditions, treatment, and patient outcomes. One presentation, spearheaded by Dr. Adam Weinstein, MD, and…

Continue Reading Is There Too Much Variability in Hyperkalemia Management?
Scientists Explore the Epigenetic Causes of PAH
Photo by Robina Weermeijer on Unsplash

Scientists Explore the Epigenetic Causes of PAH

  Recently, researchers from European Molecular Biology Laboratory (EMBL) looked to understand the cause of pulmonary arterial hypertension (PAH). They collaborated with Stanford University through the Life Sciences Alliance. Because…

Continue Reading Scientists Explore the Epigenetic Causes of PAH